Director, Clinical Development (MD) at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

PhD/PharmD and 8 years of experience OR MD (or equivalent medical degree) and 4 years’ clinical, scientific and/or drug development experience in the biopharma industry, healthcare, consulting, academia or a related environment
Preferred: MD or equivalent with board certification or eligibility in a relevant specialty (e.g., rheumatology, immunology, dermatology, or respiratory)
Preferred: Extensive experience in clinical development within the pharmaceutical or biotechnology industry, ideally in inflammation or immunology
Preferred: Proven track record of leading clinical trials from Phase 1 through Phase 3
Preferred: Strong understanding of regulatory requirements and clinical trial design
Preferred: Excellent communication, leadership, and cross-functional collaboration skills
Preferred: Experience interacting with regulatory agencies and external stakeholders
People Leader Accountabilities: Create Inclusion (knowing the business value of diverse teams, modeling inclusion, and embedding the value of diversity in team management); Develop Talent (understand skills, experience, aspirations and potential of employees and coach on performance and potential); Empower Teams (connect team to organization by aligning goals, purpose, and objectives, hold accountable, remove barriers, and connect to broader ecosystem)

Responsibilities

Lead the development and execution of clinical trial protocols for inflammation programs, ensuring scientific rigor and regulatory compliance
Serve as the clinical lead on cross-functional study teams, providing medical and strategic input throughout the clinical development lifecycle
Analyze and interpret clinical trial data; contribute to clinical study reports, regulatory submissions, and publications
Collaborate with external experts, investigators, and regulatory authorities to support program objectives
Contribute to the development of long-term clinical strategies and lifecycle management plans
Mentor and develop junior clinical team members, fostering a culture of scientific excellence and collaboration
Represent Clinical Development in internal governance and external scientific forums

Skills

Clinical Development

Clinical Trials

Protocol Design

Regulatory Compliance

Data Analysis

Clinical Strategy

Cross-Functional Collaboration

Inflammation Diseases

Study Reports

Medical Doctor

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free